West Pharmaceutical Services, Inc.WSTNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-0.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.84% |
| Q3 2025 | 9.80% |
| Q2 2025 | 23.21% |
| Q1 2025 | -24.74% |
| Q4 2024 | 1.67% |
| Q3 2024 | 28.29% |
| Q2 2024 | 2.99% |
| Q1 2024 | -25.56% |
| Q4 2023 | -10.73% |
| Q3 2023 | 2.03% |
| Q2 2023 | 11.82% |
| Q1 2023 | 3.52% |
| Q4 2022 | -13.75% |
| Q3 2022 | -16.21% |
| Q2 2022 | 19.86% |
| Q1 2022 | 3.26% |
| Q4 2021 | -1.42% |
| Q3 2021 | -12.58% |
| Q2 2021 | 16.42% |
| Q1 2021 | 47.42% |
| Q4 2020 | 14.62% |
| Q3 2020 | -1.39% |
| Q2 2020 | 28.05% |
| Q1 2020 | 7.78% |
| Q4 2019 | 7.10% |
| Q3 2019 | -5.67% |
| Q2 2019 | 13.95% |
| Q1 2019 | -21.72% |
| Q4 2018 | 60.81% |
| Q3 2018 | -0.92% |
| Q2 2018 | 11.20% |
| Q1 2018 | -18.30% |
| Q4 2017 | 32.96% |
| Q3 2017 | -16.30% |
| Q2 2017 | -12.34% |
| Q1 2017 | 14.07% |
| Q4 2016 | 1.50% |
| Q3 2016 | -13.07% |
| Q2 2016 | 104.00% |
| Q1 2016 | -33.63% |